The Vigabatrin REMS Program is required by the FDA to make certain informed risk-benefit choices prior to starting therapy, and to ensure ideal use vigabatrin while individuals are treated. It is not feasible for your healthcare provider to recognize when vision loss will certainly happen.
It is recommended that your doctor test your (or your youngster's) vision prior to or within 4 weeks after starting SABRIL and at least every 3 months during treatment up until SABRIL is quit. If you or your child have any side effect that troubles you or that does not go away, inform your medical care carrier.
Tell your doctor if you are pregnant or mean to obtain pregnant. If vision testing can not be done, your healthcare provider may proceed prescribing SABRIL, yet will not be able to expect any kind of vision loss. If vision tests are not done on a regular basis, your doctor may stop recommending SABRIL for you (or your kid).